Identification of metabolic pathways contributing to ER
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
26 07 2023
26 07 2023
Historique:
received:
27
02
2023
accepted:
21
07
2023
medline:
28
7
2023
pubmed:
27
7
2023
entrez:
26
7
2023
Statut:
epublish
Résumé
African American (AA) women in the United States have a 40% higher breast cancer mortality rate than Non-Hispanic White (NHW) women. The survival disparity is particularly striking among (estrogen receptor positive) ER
Identifiants
pubmed: 37495653
doi: 10.1038/s41598-023-39215-1
pii: 10.1038/s41598-023-39215-1
pmc: PMC10372029
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
12136Subventions
Organisme : NIBIB NIH HHS
ID : T32EB019944
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA202997
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA203000
Pays : United States
Organisme : NIBIB NIH HHS
ID : T32 EB019944
Pays : United States
Organisme : NCI NIH HHS
ID : U54CA203000
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA202995
Pays : United States
Informations de copyright
© 2023. The Author(s).
Références
Cancer Res. 2002 Jan 1;62(1):67-74
pubmed: 11782361
Transl Cancer Res. 2019 Apr;8(2):683-692
pubmed: 35116801
Signal Transduct Target Ther. 2018 Nov 9;3:30
pubmed: 30416760
Breast Cancer Res Treat. 2016 Jun;157(3):575-86
pubmed: 27255533
Am J Clin Nutr. 2017 Aug;106(2):637-649
pubmed: 28659298
Cancer Lett. 2001 Jun 10;167(1):99-104
pubmed: 11323104
J Health Care Poor Underserved. 2011 Feb;22(1):128-41
pubmed: 21317511
Breast Cancer Res Treat. 2017 Jun;163(2):321-330
pubmed: 28251385
Sci Rep. 2017 May 11;7(1):1715
pubmed: 28496143
Circ Res. 2022 Sep 16;131(7):601-615
pubmed: 36052690
Cancer Res. 2019 May 15;79(10):2494-2510
pubmed: 30862719
Technol Cancer Res Treat. 2004 Dec;3(6):551-6
pubmed: 15560712
Mol Cancer Res. 2020 Jun;18(6):883-890
pubmed: 32165453
Breast Cancer Res Treat. 2007 Aug;104(2):181-9
pubmed: 17061040
Clin Cancer Res. 2017 Mar 15;23(6):1422-1431
pubmed: 28082280
Mol Oncol. 2015 Jan;9(1):128-39
pubmed: 25151299
Dis Model Mech. 2018 May 3;11(8):
pubmed: 29739810
Cancer Res. 2010 Nov 1;70(21):8309-18
pubmed: 20959483
Nature. 2020 Jun;582(7813):586-591
pubmed: 32494005
Cancer Genomics Proteomics. 2014 Nov-Dec;11(6):279-94
pubmed: 25422359
BMC Genomics. 2020 Jan 2;21(1):6
pubmed: 31898477
Clin Chim Acta. 2013 Sep 23;424:3-7
pubmed: 23669185
Cancer. 2016 Jul 15;122(14):2138-49
pubmed: 26930024
Int J Mol Sci. 2019 Oct 09;20(20):
pubmed: 31600976
Cancer. 2011 Jan 1;117(1):180-9
pubmed: 20939011
Science. 2020 Apr 10;368(6487):
pubmed: 32273439
Eur J Biochem. 1993 Jun 15;214(3):671-6
pubmed: 8319678
Trends Biochem Sci. 2016 Aug;41(8):712-730
pubmed: 27345518
Oncogene. 2017 Jun 15;36(24):3359-3374
pubmed: 28092669
OMICS. 2013 Dec;17(12):627-35
pubmed: 24117402
Breast Cancer Res Treat. 2011 Jun;127(3):729-38
pubmed: 21076864
Cancer Res. 2011 May 1;71(9):3236-45
pubmed: 21415164
Oncotarget. 2018 Feb 7;9(14):11677-11690
pubmed: 29545929
Cancer. 2002 Jun 1;94(11):2844-54
pubmed: 12115371
ABNF J. 2006 Spring;17(2):89-94
pubmed: 18402350
Cancer. 2019 Mar 15;125(6):921-932
pubmed: 30602056
Horm Cancer. 2020 Feb;11(1):17-33
pubmed: 31858384
N Engl J Med. 2003 Nov 20;349(21):2042-54
pubmed: 14627790
Cancer. 1998 Apr 1;82(7):1310-8
pubmed: 9529023
Cancers (Basel). 2020 Aug 24;12(9):
pubmed: 32847042
Sci Rep. 2020 Nov 5;10(1):19128
pubmed: 33154507
Cancer. 2014 Dec 1;120 Suppl 23:3771-80
pubmed: 25412389
Nat Rev Cancer. 2007 Oct;7(10):763-77
pubmed: 17882277
JAMA. 2015 Jan 13;313(2):165-73
pubmed: 25585328
Ann Oncol. 2011 Jun;22(6):1295-1301
pubmed: 21199886
J Clin Oncol. 2010 Sep 20;28(27):4135-41
pubmed: 20697082
Nat Commun. 2020 Jan 16;11(1):320
pubmed: 31949157
Front Cell Dev Biol. 2021 Dec 24;9:793428
pubmed: 35004688
J Clin Invest. 2014 Jan;124(1):398-412
pubmed: 24316975
Nat Commun. 2021 Mar 19;12(1):1786
pubmed: 33741974
J Natl Cancer Inst. 2018 Jun 1;110(6):588-597
pubmed: 29325144
J Clin Oncol. 2006 Mar 20;24(9):1342-9
pubmed: 16549828
Int J Cardiol. 2018 Nov 15;271:336-339
pubmed: 30049487
PLoS One. 2017 Jun 2;12(6):e0177678
pubmed: 28574989
Breast Cancer Res Treat. 2019 Aug;176(3):687-696
pubmed: 30771047
Cancer. 2003 Sep 1;98(5):894-9
pubmed: 12942554
Breast J. 2017 Mar;23(2):177-181
pubmed: 28299888
J Clin Invest. 2018 Jan 2;128(1):323-340
pubmed: 29202474
Nat Rev Genet. 2012 May 29;13(7):484-92
pubmed: 22641018
Cancers (Basel). 2021 Mar 06;13(5):
pubmed: 33800852
Mol Cancer Res. 2022 Jun 3;20(6):923-937
pubmed: 35259269
Endocrinology. 2023 Apr 17;164(6):
pubmed: 37170651
Clin Cancer Res. 2009 Jan 15;15(2):431-40
pubmed: 19147747
Nutr Cancer. 2008;60(4):492-504
pubmed: 18584483
Metabolomics. 2016;12:58
pubmed: 27073350
Mol Cell. 2019 Sep 19;75(6):1147-1160.e5
pubmed: 31420217
Cancer Epidemiol Biomarkers Prev. 2021 Feb;30(2):351-363
pubmed: 33355191
Transl Oncol. 2013 Dec 01;6(6):757-65
pubmed: 24466379